Chinese biopharma firm EpimAb bags $120m Series C co-led by CMBI, Mirae Asset

Chinese biopharma firm EpimAb bags $120m Series C co-led by CMBI, Mirae Asset

Photo: Pixabay

Liya Su

23 March, 2021

CMB International (CMBI)Epimab BiotherapeuticsMirae Asset Financial Group

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.